| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 76 |
| 1 | CYCLOPHOSPHAMIDE | 73 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 73 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 73 |
| 4 | METHYLPREDNISOLONE | 72 |
| 5 | ASPIRIN | 60 |
| 6 | DEXAMETHASONE | 59 |
| 7 | DEXAMETHASONE 1.5 MG | 58 |
| 8 | ASPIRIN 325 MG | 57 |
| 9 | ASPIRIN 81 MG | 57 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRILLIANT BLUE G | 1 | 0.0476 |
| 1 | SERTACONAZOLE NITRATE | 6 | 0.0370 |
| 2 | MEFLOQUINE HYDROCHLORIDE | 1 | 0.0064 |
| 3 | BROMOCRIPTINE MESYLATE | 4 | 0.0062 |
| 4 | ISOPROTERENOL HYDROCHLORIDE | 2 | 0.0046 |
| 5 | ACITRETIN | 22 | 0.0045 |
| 6 | METYRAPONE | 4 | 0.0040 |
| 7 | DEFLAZACORT | 10 | 0.0039 |
| 8 | TRIMIPRAMINE | 4 | 0.0036 |
| 9 | CARMUSTINE | 16 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 191 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 114 |
| 2 | Alkylating Drug [EPC] | 86 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 82 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 70 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 63 |
| 6 | Benzodiazepine [EPC] | 61 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 57 |
| 8 | Factor Xa Inhibitor [EPC] | 56 |
| 9 | Proton Pump Inhibitor [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Disclosing Agent [EPC] | 1 | 0.0476 |
| 1 | Adrenal Steroid Synthesis Inhibitor [EPC] | 4 | 0.0040 |
| 2 | Ergot Derivative [EPC] | 12 | 0.0024 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 19 | 0.0022 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 11 | 0.0014 |
| 5 | Rifamycin Antimycobacterial [EPC] | 3 | 0.0009 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 7 | beta Lactamase Inhibitor [EPC] | 3 | 0.0007 |
| 8 | Somatostatin Analog [EPC] | 4 | 0.0006 |
| 9 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 14 | 0.0006 |